SIG | Quality and Safety: Continuous EEG/LTM–Who Do We Monitor vs. Who Should We Monitor?
Tuesday, December 7, 2021
-
You may need to log in to view video on this page.
OVERVIEW:
This Special Interest Group explores both academic and practical aspects in the application of cEEG, particularly with how cEEG is currently being utilized and opportunities to refine use of cEEG.
Use of continuous EEG (cEEG) has exploded in the past decade. While cEEG can enhance many aspects of patient care, cEEG is a limited, resource-intensive procedure. Practical guidance for pragmatic implementation is lacking. The 2015 American Clinical Neurophysiology Society (ACNS) consensus guidelines for cEEG in critically ill patients and 2021 ACNS cEEG terminology revision have provided quality standards for how to monitor patients. However, hospital systems and epilepsy centers vary widely in availability of cEEG and cEEG employment for screening, diagnosis, and treatment evaluation.
In a panel format, expert speakers examine current recommendations for cEEG, patient selection, using EEG to risk stratify patients, and practical challenges to delivery including considerations of access and equity.
Learning Objectives:
Following participation in this activity, participants will be able to:
- Describe the optimal use of cEEG and identify barriers to implementation
- Demonstrate an understanding of practical approaches for patient selection for cEEG
- Examine novel modalities and opportunities to increase access to cEEG
Program:
SIG Coordinators: Gabriel Martz, MD, FAES, and Susanna O'Kula, MD
Chair: Gabriel Martz, MD, FAES
Current Recommendations for cEEG | Susan Herman, MD, FAES
Patient Selection for cEEG | Stephen Hantus, MD
EEG to Risk Stratify Patients | Aaron Struck, MD
Practical Challenges to Delivery and Access | Suzette LaRoche, MD